The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

In the News

Paula Hammond

Incorporating Diversity

Paula Hammond spoke to The New York Times about a recent uptick in the diversity of corporate boards and the advantages of bringing different perpectives, knowledge, and experience into the boardroom. Hammond, an Institute Professor who also serves on President Biden’s Council of Advisors on Science and Technology, was approached for the first time in 2020 to serve on a board.   more...

pink Sherlock Holmes silhouette on a purple background

Nano-mentary, My Dear Watson

Upstage Lung Cancer’s podcast episode, “What If Sherlock Holmes Had Cancer,” explores the use of nanoparticles to detect early clues to lung cancer. Expert witnesses include KI trainees Jesse Kirkpatrick and Christina Cabana, Marble Center for Cancer Nanomedicine Assistant Director Tarek Fadel, and KI Executive Director Jane Wilkinson. more...

pancreatic cancer cells stained to reflect cell state

Swing States

Analyzing the RNA expression patterns of cancer cells can reveal their susceptibility to different drugs, according to new work from Shalek and Manalis lab researchers and their Bridge Project collaborators. In a study of pancreatic cancer cells, published in Cell, the team also demonstrated that changes to the tumor microenvironment can drive cells from one RNA-expression state to another. Their findings suggest that it may be possible to treat some patients’ tumors more effectively by first modifying signals in the tumor microenvironment to lock it in a particular state, and then giving a drug that targets that state.

The work was funded in part by the Bridge Project and the Ludwig Center for Molecular Oncology at MIT. more...

a lecturer and a projected slide with graphs

Intermural Networks

Researchers from MIT’s Jameel Clinic for Machine Learning and the Koch Institute came together to discuss applications of machine learning and artificial intelligence in the study, detection, and treatment of cancer. The meeting, which included research presentations and a networking reception, laid the groundwork for future collaboration, partnerships, and exchanges. more...

Kristin Knouse at MIT

Organ-ic Questions in Cancer Biology

New KI faculty member Kristin Knouse studies regeneration in the liver to understand how tissues sense and respond to damage. As a clinically trained cell biologist, Knouse has a joint interest in medical applications and fundamental biological questions, including how seemingly dormant cancer cells drive metastatic disease. more...

macrophages, B cell follicles and lymphatic vasculature in a lymph node

More Powerful Vaccines

A potent adjuvant from the Irvine Lab significantly improves antibody production in mice after vaccination against HIV, diphtheria, and influenza. The immune system-boosting nanoparticle, described in a study published in Science Immunology and funded in part by the Marble Center for Cancer Nanomedicine, may also have applications for vaccines against Covid-19 and cancer. more...

Paula Hammond standing in front of a mural

Standing Innovation

Congratulations to Paula Hammond on her election to the National Academy of Inventors Fellows Program. The program highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on the quality of life, economic development, and the welfare of society. more...

Laurie Boyer and Kristin Knouse

Creating a Cohort

Following on last year’s boot camp, the MIT Future Founders Initiative, initiated by KI members Sangeeta Bhatia, Susan Hockfield, and Nancy Hopkins, announced its $250K prize competition to promote female entrepreneurs in biotech. KI faculty members Laurie Boyer and Kristin Knouse are among the finalists, as is KI alum Canan Dagdeviren. Learn more about the program's origins and goals in Bhatia's recent interview with the Kendall Square Association. more...

Blue-stained protein found on dendritic cell surfaces

Immune Cell Masquerade

Spranger Lab researchers describe how a subset of immune cells known as type-2 conventional dendritic cells (DC2) cloak themselves in cancer-associated proteins to provoke an immune response against tumors. Their findings, published in Immunity, indicate that these stealthy operations are driven by the signaling molecule type-1 interferon, suggesting new strategies for targeted immunotherapy. Read lead author Brendan Horton's interview with News Medical here. more...

a finger points to a bright spot on a mammogram image

Mirai Goes Global

Mirai, a machine learning model for breast cancer risk prediction, is heading to seven hospitals around the world. Researchers hope to minimize Mirai’s bias by testing its performance in patient populations with diverse clinical and demographic backgrounds. The model was developed by a team led by KI member Regina Barzilay and was recently featured in The Washington Post and on Good Morning America. more...